ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,013.13
-1.71%
US Tech 100
21,038.40
-2.10%
다우존스 지수
43,428.02
-1.69%
Bitcoin
96,311.81
0.18%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ

  6. Estrella Immunopharma Inc (ESLA) 시세

Estrella Immunopharma Inc

Estrella Immunopharma Inc (ESLA)

NASDAQ
1.48
-0.01
(-0.67%)
마감 22 2월 6:00AM
15분 지연
1.45
-0.03
(-2.03%)
시간외 거래: 9:35AM
15분 지연

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
1.45
매수가
1.40
매도가
1.52
거래량
648,360
1.42 일간 변동폭 1.78
0.63 52주 범위 3.23
market_cap
52.46M
전일 종가
1.49
개장가
1.69
최근 거래 시간
80
@
1.48
마지막 거래 시간
재정 규모
US$ 1,057,545
VWAP
1.6311
평균 볼륨(3m)
46,136
발행 주식
36,179,147
배당수익률
-
주가수익률
-7.22
주당순이익(EPS)
-0.2
매출
-
순이익
-7.31M

Estrella Immunopharma Inc 정보

Estrella Immunopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases. Its lead product candidate, EB103, utilizes Eureka's ARTEMIS technology to target CD19, a protein expressed o... Estrella Immunopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune diseases. Its lead product candidate, EB103, utilizes Eureka's ARTEMIS technology to target CD19, a protein expressed on the surface of almost all B-cell leukemias and lymphomas. The Company is also developing EB104, which also utilizes Eureka's ARTEMIS technology to target not only CD19, but also CD22, a protein that, like CD19, is expressed on the surface of most B-cell malignancies. The Company is also collaborating with Imugene Limited and its product candidate, CF33-CD19t an oncolytic virus (CF33-CD19t), to research the use of EB103 in conjunction with CF33-CD19t to treat solid tumors. Its EB201 program, in preclinical development, is being explored as a potential therapeutic approach targeting Systemic Lupus Erythematosus (SLE). 더 보기

섹터
Blank Checks
산업
Biological Pds,ex Diagnstics
본부
Wilmington, Delaware, USA
설립됨
2021
Estrella Immunopharma Inc is listed in the Blank Checks sector of the 나스닥 with ticker ESLA. The last closing price for Estrella Immunopharma was US$1.49. Over the last year, Estrella Immunopharma shares have traded in a share price range of US$ 0.63 to US$ 3.23.

Estrella Immunopharma currently has 36,179,147 shares in issue. The market capitalisation of Estrella Immunopharma is US$53.91 million. Estrella Immunopharma has a price to earnings ratio (PE ratio) of -7.22.

ESLA 최신 뉴스

추가 뉴스
기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.2722.88135593221.181.741.182506131.43744929CS
40.2722.88135593221.181.741.03598571.39880034CS
120.3430.63063063061.111.741.02461361.32777649CS
260.064.316546762591.391.740.63864761.18502875CS
520.4240.77669902911.033.230.63730191.4256036CS
156-3.76-72.16890595015.215.620.63730841.54884233CS
260-3.76-72.16890595015.215.620.63730841.54884233CS

ESLA - Frequently Asked Questions (FAQ)

What is the current Estrella Immunopharma share price?
The current share price of Estrella Immunopharma is US$ 1.45
How many Estrella Immunopharma shares are in issue?
Estrella Immunopharma has 36,179,147 shares in issue
What is the market cap of Estrella Immunopharma?
The market capitalisation of Estrella Immunopharma is USD 53.91M
What is the 1 year trading range for Estrella Immunopharma share price?
Estrella Immunopharma has traded in the range of US$ 0.63 to US$ 3.23 during the past year
What is the PE ratio of Estrella Immunopharma?
The price to earnings ratio of Estrella Immunopharma is -7.22
What is the reporting currency for Estrella Immunopharma?
Estrella Immunopharma reports financial results in USD
What is the latest annual profit for Estrella Immunopharma?
The latest annual profit of Estrella Immunopharma is USD -7.31M
What is the registered address of Estrella Immunopharma?
The registered address for Estrella Immunopharma is 108 W. 13TH STREET, SUITE 100, WILMINGTON, DELAWARE, 19801
Which industry sector does Estrella Immunopharma operate in?
Estrella Immunopharma operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
BOXLBoxlight Corporation
US$ 3.1099
(51.70%)
1.84M
GDEVGDEV Inc
US$ 20.90
(46.56%)
264.44k
IVVDInvivyd Inc
US$ 1.7501
(44.64%)
37.75M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
DOYUDouYu International Holdings Ltd
US$ 7.19
(-55.31%)
1.28M
MNDRMobile health Network Solutions
US$ 0.5048
(-46.29%)
18.61M
BLUEbluebird bio Inc
US$ 4.09
(-41.90%)
5.44M
FLDFold Holdings Inc
US$ 6.95
(-37.39%)
488.54k
GCLGCL Global Holdings Ltd
US$ 3.83
(-31.48%)
635.26k
MLGOMicroAlgo Inc
US$ 6.3767
(454.50%)
531.54M
UPCUniverse Pharmaceuticals Inc
US$ 0.2003
(40.56%)
420.21M
ADTXAditxt Inc
US$ 0.0922
(-22.39%)
278.25M
NVDANVIDIA Corporation
US$ 134.43
(-4.05%)
228.14M
HOLOMicroCloud Hologram Inc
US$ 1.565
(31.51%)
190.81M

ESLA Discussion

게시물 보기
81vette 81vette 8 시간 전
Scanners will find this,mine did,it will only take 1 with 20k+ followers to promote this and with the current no manipulation(freely trading) it could jump up quickly
👍️0
81vette 81vette 8 시간 전
new bio pharma,trading freely,72%inside!10m float,45Xs buying ave.(serious loading,on 1st trial news)
👍️0
81vette 81vette 9 시간 전
Golden cross https://stockcharts.com/h-sc/ui?s=esla
👍️0
81vette 81vette 10 시간 전
Buys 2x the sells,nearly no dark trades https://ih.advfn.com/stock-market/NASDAQ/estrella-immunopharma-ESLA/trades
👍️0
81vette 81vette 10 시간 전
Nice chart,moving freely is rare!
In 10k@1.55
👍️0
tedpeele tedpeele 12 시간 전
ESLA $16 12 month price target, news today - moving forward
👍️0
tedpeele tedpeele 12 시간 전
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
4:46 PM ET 2/19/25 | BusinessWire

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
EMERYVILLE, Calif.--(BUSINESS WIRE)--February 19, 2025--

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS(R) T-cell therapies to treat cancer and autoimmune diseases, today announced that D. Boral Capital LLC ("D. Boral Capital"), a leading investment bank, has initiated coverage on the Company, assigning a Buy rating to Estrella and established a 12-month price target of $16.00.

Valuation Highlights
-- D. Boral Capital's analysis focuses on the development of EB103 in B-cell
Non-Hodgkin's Lymphoma, emphasizing Estrella's ARTEMIS(R) T-cell
engineering platform that utilizes cellular mechanisms which closely
resemble those of endogenous T-cell receptors, producing a more natural
and regulated immune response.

-- The derived 12-month price target of $16.00 underscores market confidence
in Estrella's potential to capture significant market share in
immuno-oncology.

-- The models incorporate a 30% probability of success along with a 30%
discount rate, reflecting the early stage of Estrella's clinical
development.
👍️0
Monksdream Monksdream 2 월 전
ESLA, under $2
👍️0
glenn1919 glenn1919 2 월 전
ESLA.......................https://stockcharts.com/h-sc/ui?s=ESLA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 2 월 전
ESLA..........................https://stockcharts.com/h-sc/ui?s=ESLA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 월 전
ESLA...................................https://stockcharts.com/h-sc/ui?s=ESLA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 월 전
ESLA......................................https://stockcharts.com/h-sc/ui?s=ESLA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 월 전
ESLA....................................https://stockcharts.com/h-sc/ui?s=ESLA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 3 월 전
ESLA........................................https://stockcharts.com/h-sc/ui?s=ESLA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 월 전
ESLA.........................................https://stockcharts.com/h-sc/ui?s=ESLA&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 월 전
ESLA.....................https://stockcharts.com/h-sc/ui?s=ESLA&p=W&b=5&g=0&id=p86431144783
👍️0

최근 히스토리

NASDAQ
ESLA
Estrella Immunopharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지